Wird geladen...
Disease modifying potential of glatiramer acetate in Huntington's disease
BACKGROUND: Deficiencies in brain-derived-neurotrophic-factor have been implicated in the pathogenesis of Huntington's disease (HD). OBJECTIVE: Glatiramer acetate, an FDA- approved drug used for the treatment of multiple sclerosis, has been shown to increase brain-derived-neurotrophic-factor le...
Gespeichert in:
| Veröffentlicht in: | J Huntingtons Dis |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4480978/ https://ncbi.nlm.nih.gov/pubmed/25300334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JHD-140110 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|